Home
About Us
Services
Markets
Resarch
Online Trading
Back Office
Contact Us
Download
Equities
Top Gainers & Losers
Advances & Declines
New Highs & Lows
Value Toppers
Volume Toppers
52 Week High & Low
News Analysis
Pre-Session
Mid-Session
End-Session
Market Beat
Hot Pursuit
Stock Alert
Economy News
Corporate News
Foreign Markets
Corporate Results
Other Markets
Corporate Action
BSE Announcements
NSE Announcements
Board Meetings
Book Closure
Bonus Issues
Rights Issues
Delisted Shares
Market Turnover
Change Of Names
Split Of Face Value
Other Markets
ADR Prices
GDR Prices
World Indices
Forex Details
Company Profile
Detailed Quotes
Company Background
Board Of Directors
Balance Sheet
Profit And Loss
Quarterly Results
Financial Ratios
Share Price
Technical Chart
Mutual Fund
Fund Profile
Fund Performance
Fund Ranking
Scheme Profile
Daily NAV
MF Synopsis
Historical NAV
Dividend Details
MF News
MF Activity
Top 10 Holdings
New Fund Offer
Returns Calculator
SIP Calculator
IPO
Forthcoming Issues
Open Issues
Closed Issues
New Listing
Basis Of Allotment
Draft Prospectus
New Issue Monitor
BACK
Your are on :
Markets |
IPO
|
IPO Synopsis
As on: Apr 25,2024 03:14 PM
Gland Pharma Ltd
Registered Office:
Sy No 143-148 150&151 Nr Gandi,X Roads D P Pally Dundigal, Hyderabad - 500043, Telangana, India.
Phone : 91-40-30510999 Fax:91-40-30510800
Email :
investors@glandpharma.com
Website :
www.glandpharma.com
Initial public offer of 43196968 equity shares of face value of Re. 1 each ("equity shares") of Gland Pharma Limited ("Company" or "Issuer") for cash at a price of Rs.1500 Per equity share (including a share premium of Rs.1499 per equity share) aggregating Rs.6479.55 crores (The "Offer") comprising a fresh issue of 8,333,333 equity shares aggregating up to Rs. 1250 crores on (The "fresh issue") and an offer for sale of 34,863,635 equity shares, including 19,368,686 equity shares by Fosun Pharma Industrial Pte. Ltd ("promoter selling shareholder") and 10,047,435 equity shares by Gland Celsus Bio Chemicals Private Limited, 3,573,014 equity shares By Empower Discretionary Trust, and 1,874,500 equity shares by Nilay Discretionary Trust (collectively, the "other selling shareholders" and collectively With the promoter selling shareholder are referred to as the "selling shareholders", and such equity shares, the "offered shares") aggregating up to Rs. 5229.55 crores (the "offer for sale"). The offer shall constitute 26.46% of the post-offer paid-up equity share capital of the company. The face value of Equity shares is Re.1 each. The offer price is Rs.1500 per equity share and is 1500 times the face value of the Equity Shares. The Anchor Investor Offer Price is Rs.1500 per Equity Share.
Issue
Money Payable On
Opens On
Closes On
Application
Allotment
09-Nov-20
11-Nov-20
1500.00-0.00
0.00-0.00
Minimum Application for shares in Nos : 10 Further Multiples of : 10
(
R
s
)
Lead Managers to the Issue
Project Cost
1250.00
Citigroup Global Markets India Pvt Ltd
Project Financed through Current Offer
6479.55
Post Issue Equity Share Capital
163.28
Issue Price
1500.00
Projects
Funding incremental working capital requirements of the company
Funding capital expenditure requirements of the company
General corporate purposes
Promoted By
Fosun Pharma Indust. Pte. Ltd
Shanghai Fosun Pharma. Group
Listing At
BSE
NSE
Registrar to the Issue
No Data Available
Product
Disclaimer
Mandatory Information
Privacy Policy
Careers
Risk disclosures
Feedback
Scores
Investor Charter
STOCK BROKER
DEPOSITORY PARTICIPANTS
INVESTOR GRIEVANCES ESCALATION MATRIX
Member Bank Details
"Investor Grievance"
Mail your Grievance to
info@lalkar.in
Important Links:
SEBI
|
NSE
|
BSE
|
MCX-SX
|
MCX
|
NCDEX
|
NSDL
|
CDSL
|
FMC
|
CDSL E-Voting
|
SMART ODR
SEBI REGISTRATION NOS - BSE CASH: INZ000269434 | BSE FNO: INZ000269434 | NSE CASH: INZ000269434 | NSE FNO: INZ000269434 | NSE CD: INZ000269434 | MSEI CASH: INZ000269434 | MSEI FNO: INZ000269434 | MSEI CD: INZ000269434
AMFI NO : ARN- 19226 | LALKAR COMMODITIES PVT. LTD.: MCX: 10685 FMC: MCX/TCM/CORP/0655 | NSEL: 11300 | NCDEX: 1130 FMC No : NCDEX/TCM/CORP/1106
2010 © Lalkar Group. All rights reserved
Designed, developed & powered by
CMOTS Infotech
(ISO 9001:2015 certified)